Long-term results after carinal resection for carcinoma: Does the benefit warrant the risk?  by de Perrot, Marc et al.
de Perrot et al General Thoracic SurgeryLong-term results after carinal resection for carcinoma:
Does the benefit warrant the risk?
Marc de Perrot, MD, Elie Fadel, MD, Olaf Mercier, MD, Sacha Mussot, MD, Alain Chapelier, MD,
and Philippe Dartevelle, MD
G
TSFrom the Department of Thoracic and Vas-
cular Surgery and Heart-Lung Transplanta-
tion, Centre Chirurgical Marie-Lannelongue,
Le Plessis-Robinson, France.
Read at the Eighty-fifth Annual Meeting of
The American Association for Thoracic
Surgery, San Francisco, Calif, April 10-13,
2005.
Received for publication April 14, 2005;
revisions received July 10, 2005; accepted
for publication July 19, 2005.
Address for reprints: Philippe Dartevelle,
MD, Department of Thoracic and Vascular
Surgery and Heart-Lung Transplantation,
Centre Chirurgical Marie-Lannelongue, 133
Avenue de la Resistance, 92350 Le Plessis-
Robinson, France.
J Thorac Cardiovasc Surg 2006;131:81-9
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.07.062Objective: We sought to determine whether the benefit warrants the risk in patients
undergoing carinal resection for carcinoma.
Methods: This was a retrospective single-center study.
Results: Between June 1981 and August 2004, 119 patients underwent carinal
resection for carcinoma in our institution. Carinal pneumonectomy was performed
in 103 cases (96 right and 7 left pneumonectomies), carinal resection plus right
upper lobectomy in 3, carinal resection after left pneumonectomy in 2, and carinal
resection without pulmonary resection in 11. Superior vena caval resection was
combined with carinal pneumonectomy in 25 patients with bronchogenic carcinoma
(13 patients had complete superior vena caval resection with graft interposition).
Nine (7.6%) patients died in the hospital or within 30 days of the operation.
Follow-up was complete for 117 (98%) patients up to August 2004 or to the date of
death. The 5- and 10-year survivals were 44% and 25%, respectively, for patients
with bronchogenic carcinoma (n  100). However, survival was significantly better
in patients with N0 or N1 disease (n  73) than in those with N2 or N3 disease
(n  27; 53% vs 15% at 5 years, respectively). The 5- and 10-year survivals in the
remaining 19 patients reached 66% and 48%, respectively, and were best in patients
with neuroendocrine carcinoma (100% survival at 10 years) and adenoid cystic
carcinoma (69% survival at 10 years).
Conclusions: Surgical intervention for carcinoma involving the carina is feasible,
with acceptable mortality and good long-term survival in selected patients. The
presence of positive N2 disease should, however, be considered a potential contra-
indication to carinal resection in patients with bronchogenic carcinoma because of
the poor long-term survival.
Refinement in techniques of tracheal surgery and bronchial sleeve lobectomyhas made carinal resection and reconstruction possible. However, the po-tential for complications remains high, and few centers only have accumu-
lated sufficient expertise to safely perform the operation. Although the risks of
carinal resection and reconstruction are certainly justifiable in patients with benign
and low-grade malignancies, the usefulness of carinal surgery for carcinoma in-
volving the carina is still questionable. Few series have reported long-term survival
after carinal resection for bronchogenic carcinomas or adenoid cystic carcinomas
involving the carina.1-3 The objective of this article is to review our experience in
carinal resection for carcinoma and to determine whether the benefit warrants the
risk.
Materials and Methods
Patient Data
All patients who underwent carinal resection for carcinoma in our institution between June
1981 and August 2004 were reviewed. Patients undergoing carinal resection for benign
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from the study. Data were obtained from the hospital database,
hospital charts, referring physicians, and/or from the patients or the
patients’ family. Follow-up was completed up to August 2004 or
to the date of death. Postoperative death included all patients who
died within 30 days of surgical intervention or before being dis-
charged from the hospital. The study was approved by the insti-
tutional review board.
Preoperative Investigations
The preoperative workup has evolved over the years but cur-
rently consists of chest radiography, chest computed tomography
(CT), pulmonary function testing, arterial blood gas measurement,
ventilation-perfusion scanning, electrocardiography, and echocar-
diography. CT scanning of the upper abdomen and CT or magnetic
resonance imaging of the brain are routinely performed to exclude
distant metastasis. Bronchoscopy is always performed preopera-
tively to determine the extent of involvement and adequacy of the
remaining airway. Mediastinoscopy is performed at the time of
surgical intervention in patients presenting with bronchogenic car-
cinoma to exclude N2 disease. Bone scanning is performed in
symptomatic patients or in patients with abnormal blood work.
Stress thallium studies, maximum oxygen uptake, and exercise
testing are used when indicated.
Pulmonary angiography is performed for carinal tumors arising
from the anterior segment of the right upper lobe because invasion
of the right upper lobe (mediastinal) artery usually indirectly
reveals invasion of the posterior aspect of the superior vena cava
(SVC). Superior cavography is performed if the SVC is potentially
involved. Transesophageal echography is occasionally performed
to evaluate tumor extension to the posterior mediastinum, espe-
cially the esophagus or the left atrium.
Surgical Technique
Our technique of carinal resection has been reviewed in detail
elsewhere.4,5 Only some specific points are presented herein. The
patient is initially intubated with an extra-long oral endotracheal
tube that can be advanced into the opposite bronchus if single-lung
ventilation is desired. Once the carina has been resected, the
opposite main bronchus is intubated with a cross-field sterile
endotracheal tube connected to a sterile tubing system. After the
trachea and bronchi are anastomosed, the cross-field tube is with-
drawn, and the patient is ventilated through the endotracheal tube
left in place above the anstomosis.
The incision varies according to the type of carinal resection.
Carinal resection without sacrifice of pulmonary parenchyma is
approached through a median sternotomy. The pericardium is
opened anteriorly, and the tracheobronchial bifurcation is exposed
Abbreviations and Acronyms
CT  computed tomography
NSCLC non–small cell lung carcinoma
PTFE  polytetrafluoroethylene
SVC  superior vena cavabetween the SVC and the ascending aorta. The exposure is facil-
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pulmonary arteries. The ligamentum arteriosum is systematically
sectioned.
Right carinal pneumonectomy is performed through a right
thoracotomy in the fifth intercostal space. After division of the
azygos vein, the tracheobronchial bifurcation is mobilized. Cir-
cumferential dissection should be limited to no more than 2 cm
from the proposed lines of transection of the lower trachea and the
left main bronchus. If segmental resection of the SVC is planned,
the vascular procedure is usually performed before division of the
airway. The SVC is clamped proximally at the confluence of the
brachiocephalic veins and distally at the cavoatrial junction and
divided on each side of the tumor. Section of the SVC facilitates
exposure and stapling of the right pulmonary artery in the inter-
aortocaval groove. The SVC is reconstructed with a ringless
straight 18 or 20-mm sized polytetrafluoroethylene (PTFE) graft.
The PTFE graft is protected with gauze soaked in povidone-iodine
during reconstruction of the airway to prevent graft contamination.
Although left carinal pneumonectomy was performed through a
left thoracotomy early on in our experience, median sternotomy is
currently our preferred approach. Median sternotomy provides
superb exposure to the tracheobronchial bifurcation, has less inci-
sional discomfort, and results in less ventilatory restriction than a
thoracotomy. The main disadvantages are that freeing pleuropari-
etal adhesions can be difficult, and mobilization of the left hilum
requires cardiac retraction that might cause some hemodynamic
instability.
The tracheobronchial anastomosis is always performed in an
end-to-end fashion. We first apply a running 4-0 polydiaxone
(PDS; Ethicon, Inc, Somerville, NJ) suture on the deepest aspect of
the airway with respect to the surgeon. For instance, in a right
carinal pneumonectomy this represents the left aspect of the car-
tilage wall of the trachea and left main bronchus. The running
suture is then tied at each end with 2 independent polydiaxone
sutures, the knots of which are made outside the lumen. Thereafter,
several interrupted stitches of 3-0 polydiaxone or 3-0 Vicryl (Ethi-
con, Inc) are placed in the remaining part of the anastomosis. They
are tied after all of them have been placed to correct for size
discrepancies. The stitches applied on the membranous portion are
tied at the end to avoid any traction and potential tears.
At the end of the procedure, the anastomosis is controlled with
bronchoscopy, and secretions are cleaned up from the airways.
Patients are extubated in the operating room. Pain relief is achieved
with epidural analgesia or patient-controlled analgesia. A tempo-
rary tracheostomy can be performed at the end of operation to
reduce the physiologic respiratory dead space and facilitate direct
aspiration when the predicted residual ventilatory functional re-
serve is borderline or the patient’s collaboration is reduced.
Statistical Analysis
All results are expressed as medians and ranges or as absolute
numbers and percentages. Potential risk factors for postoperative
mortality were identified by means of univariate and multivariate
analysis. All variables were initially subjected to univariate anal-
ysis with the 2 test to avoid overadjustment by using too many
variables in the multivariate models. Factors with a P value of less
than .1 were then considered as risk factors in the multivariate
logistic regression analysis. Survival rates were calculated by
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compared with the log-rank test. Statview V (Abacus Concept,
Berkeley, Calif) software was used for all analyses.
Results
A total of 119 patients underwent carinal resection for
carcinoma over the 23-year period of the study. There were
99 men and 20 women with a median age of 55 years
(range, 36-73 years). The main clinical symptoms at pre-
sentation were hemoptysis (n  44) and dyspnea (n  29).
Indications for surgical intervention were non–small cell
lung carcinoma (NSCLC) in 100 patients, adenoid cystic
carcinoma in 8 patients, neuroendocrine carcinoma (carci-
noid tumor) in 5 patients, mucoepidermoid carcinoma in 4
patients, and metastatic renal cell carcinoma in 2 patients
(Table 1). Five patients underwent preoperative rigid bron-
choscopy with core-out of the tumor to open the distal
airways.
A total of 23 patients underwent induction therapy with
either chemotherapy (n  18) or chemoradiation therapy
(n  5) with 40 to 45 Gy of radiation. An additional 4
patients had a history of radiation therapy before carinal
resection for breast cancer (n  2) or Hodgkin’s disease
(n 1) or as adjuvant therapy after a right lower lobectomy
for bronchogenic carcinoma classified as pT2 N2.
Right carinal pneumonectomy was performed in 96 pa-
tients. Seven patients underwent a left carinal pneumonec-
tomy through a left thoracotomy (n  3) or through a
TABLE 1. Patient characteristics
Age (y)
Median 55
Range 36-73
Sex (n)
Male 99
Female 20
Clinical presentation (n)
Hemoptysis 44
Weight loss 32
Dyspnea 29
Pneumonia 19
Chest pain 18
Clubbing 5
Empyema 3
HPO 1
Hiccups 1
Diagnosis (n)
Non–small cell lung carcinoma 100
Adenoid cystic carcinoma 8
Neuroendocrine carcinoma 5
Mucoepidermoid carcinoma 4
Metastatic renal cell carcinoma 2
HPO, Hypertrophic pneumonic osteoarthropathy.median sternotomy (n 4). Two patients underwent carinal
The Journal of Thoracresection through a median sternotomy 3 and 4 weeks after
a left pneumonectomy performed in another center. Both of
these patients were referred to us because of positive mi-
croscopic bronchial margin of the left mainstem bronchial
margin at the time of pneumonectomy. Three patients had
carinal resection associated with a right upper lobectomy;
the bronchus intermedius was reimplanted into the side of
the trachea (n  2) or into the side of the left mainstem
bronchus (n  1).
A total of 11 patients had carinal resection without lung
resection. The carina was usually reconstructed with an
end-to-end anastomosis of the left mainstem bronchus into
the trachea and an end-to-side anastomosis of the right
mainstem bronchus into the trachea (n  8). In one patient
the left mainstem bronchus was too short to reach the
trachea without tension, and thus the right mainstem bron-
chus was anastomosed end-to-end to the trachea, and the left
mainstem bronchus was anastomosed end-to-side to the
bronchus intermedius. In 2 patients the carina and the right
mainstem bronchus were partially resected, and the left
mainstem bronchus was anastomosed end-to-side to the
defect.
SVC resection was combined with a right carinal pneu-
monectomy in 25 patients with bronchogenic carcinoma.
The SVC was completely resected en bloc with the tumor in
13 patients and was reconstructed with PTFE sized 16 (n 
1), 18 (n  9), or 20 (n  3). The SVC crossclamp time
ranged between 15 and 45 minutes (median, 23 minutes).
The remaining 12 patients had only partial resection of the
SVC and did not require graft interposition. One patient had
complete agenesia of the inferior vena cava and had large
collaterals draining into the azygos vein. The azygos vein
was anastomosed to the right atrium after being sectioned
from the SVC to maintain adequate venous return from the
lower part of the body. Part of the left atrium was resected
in 10 patients, the muscular wall of the esophagus in
4 patients, and the chest wall (2 ribs) or the diaphragm in
1 patient each.
Complete resection (R0) was achieved in 112 patients.
Microscopic positive resection margin (R1) was observed in
4 patients with adenoid cystic carcinoma and in 3 patients
with squamous cell carcinoma. Positive resection margins
were usually seen at the bronchial or tracheal resection
margins when the maximal length of the airway had already
been removed (n  6). In one case malignant cells were
seen at the resection margin of the left atrium. NSCLCs
were classified as squamous cell carcinoma (n  76), ade-
nocarcinoma (n  16), large cell carcinoma (n  7), and
sarcomatoid carcinoma (n  1). The nodal status of the
NSCLC was classified as pN0 in 14 patients, pN1 in 59
patients, and pN2 or pN3 in 27 patients. Tumor size ranged
between 1 and 10 cm (median, 4.5 cm).
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(Table 2). A total of 12 (10%) patients presented with
anastomotic complications (9 dehiscences and 3 local ne-
croses). All 3 patients with local necrosis were treated
conservatively, and one of them had an anastomotic stenosis
requiring an endotracheal stent later on. All 9 patients with
a tracheal dehiscence had an empyema, and 4 (44%) of them
died while in the hospital. Two patients eventually had an
anastomotic stenosis, and one required a stent insertion. A
total of 12 (10%) patients had some degree of pulmonary
edema in the immediate postoperative period. Five (42%) of
them required reintubation, and 4 (33%) died from acute
respiratory distress syndrome.
The operative mortality according to the type of proce-
dure is reported in Table 3. All deaths occurring from
tracheal dehiscence or acute respiratory distress syndrome
happened after right carinal pneumonectomy. One addi-
tional patient who underwent carinal resection and recon-
struction had mild pulmonary edema postoperatively. The
TABLE 2. Postoperative complications
n %
Cardiac
Arrhythmias 12 10.1
Myocardial infarction 1 0.8
Cardiac herniation 1 0.8
Respiratory
Pulmonary edema 12 10.1
Sputum retention 11 9.2
Pneumonia 9 7.6
Pulmonary emboli 2 1.7
Anastomotic
Dehiscence 9 7.6
Local necrosis 3 2.5
Infectious
Empyema 6 5.0
Mediastinitis 1 0.8
Wound infection 1 0.8
Other
Bleeding 3 2.5
Recurrent nerve palsy 3 2.5
Chylothorax 2 1.7
TABLE 3. Operative mortality according to the type of
carinal resection
Procedure n Operative death
Right carinal pneumonectomy 96 8 (8.3%)
Left carinal pneumonectomy 7 0
Carinal resection after left pneumonectomy 2 0
Carinal plus right upper lobectomy 3 0
Carinal resection without lung resection 11 1 (9%)
Overall 119 9 (7.6%)
84 The Journal of Thoracic and Cardiovascular Surgery ● Januapatient recovered rapidly and was discharged from the hos-
pital on the 14th postoperative day but died at home on the
30th postoperative day from acute pulmonary emboli. The
predominant risks of postoperative death identified by using
univariate and multivariate analyses were the development
of pulmonary edema and the occurrence of tracheal dehis-
cence in the postoperative period (Table 4). Other factors,
such as preoperative radiation therapy, sputum retention,
histology, or type of operation, had no significant effect on
the risk of postoperative death. Although induction therapy
also had no significant effect on the risk of postoperative
death, there was a trend toward a higher mortality rate in
patients undergoing right carinal pneumonectomy after in-
duction therapy (operative mortality of 13% vs 6.7% in
patients undergoing right carinal pneumonectomy without
induction therapy, P  .3).
Follow-up was completed up to August 2004 or to the
date of death for 117 (98%) patients. Two patients who
migrated outside of France were lost to follow-up 1 and 6
years after their operations. Thirty-eight patients had adju-
vant therapy with either chemotherapy, radiation therapy, or
TABLE 4. Risk factors for postoperative death
P value
Risk factors
No. of
patients
No. of
deaths
Univariate
analysis
Multivariate
analysis
Bronchogenic carcinoma .2 —
Yes 100 9
No 19 0
Induction therapy .3 —
Yes 23 3
No 96 6
Preoperative radiation .4 —
Yes 9 0
No 110 9
Sputum retention .3 —
Yes 11 0
No 108 9
Right pneumonectomy .5 —
Yes 96 8
No 23 1
Superior vena cava
resection
.07 .09
Yes 25 4
No 94 5
Postoperative pulmonary
edema
.0001 .0001
Yes 12 6
No 107 3
Anastomotic dehiscence .0001 .001
Yes 9 4
No 110 5both. Six patients had an empyema between 2 weeks and 9
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an anastomotic fistula, and all were successfully treated with
a Clagett window.
The actuarial 5- and 10-year survivals were, respectively,
44% and 25% for patients with bronchogenic carcinoma
(Figure 1). However, survival reached 53% at 5 years in
patients with N0 or N1 disease and was significantly better
than in those with N2 or N3 disease (survival of 15% at 5
years; Figure 2). There was no difference in survival at 5
years between patients with N0 or N1 disease (50% vs 55%,
respectively; P .9). The actuarial 5- and 10-year survivals
were 41% and 30%, respectively, in patients who underwent
resection of the SVC (P  .9 when compared with the
remaining cohort of patients with bronchogenic carcinoma).
Recurrences were observed at the anastomotic site in 5
patients (all of them had negative resection margins), in the
mediastinum in 4 patients, and at distant sites in the remain-
ing patients.
The actuarial 5- and 10-year survivals in the remaining
19 patients reached 66% and 48%, respectively. Two pa-
tients with adenoid cystic carcinoma died 16 and 23 months
after the operation, respectively, whereas the remaining 6
patients are alive 16 to 192 months after the operation
(median, 26 months), leading to an actuarial 10-year sur-
vival rate of 69%. All patients with neuroendocrine carci-
noma are alive 25 to 126 months after the operation (me-
dian, 35 months), leading to an actuarial 10-year survival of
100%. Among the 4 patients with mucoepidermoid carci-
noma, 2 are alive 16 and 22 months after the operation,
Figure 1. Actuarial survival for patients with bronchogenic car-
cinoma undergoing carinal resection, including the operative
deaths. The estimated 5-, 10-, and 15-year survivals were 44%,
25%, and 11%, respectively. A total of 30 patients were alive at 5
years, 11 at 10 years, and 4 at 15 years.whereas 2 died 27 and 70 months after the operation. The
The Journal of Thorac2 patients with metastastic renal cell carcinoma died 22 and
23 months, respectively, after the operation.
Discussion
The optimal treatment for carcinoma involving the carina is
still debated. Surgical intervention is infrequently proposed
because of the complexity of the operation and the paucity
of data demonstrating benefit in the long term. The results of
this study demonstrate that carinal resection for carcinoma
is relatively safe in experienced centers and can be associ-
ated with good long-term survival in selected patients. All
patients undergoing carinal resection for neuroendocrine
carcinoma are alive after 25 to 126 months, and 6 of 8
patients with adenoid cystic carcinoma are alive 16 to 192
months after the operation. In addition, 30 of the 100
patients presenting with bronchogenic carcinoma were alive
at 5 years, leading to an actuarial 5-year survival of 53% if
the mediastinal nodes were negative.
Our overall operative mortality of 7.6% compares favor-
ably with that seen in other recent series. Mitchell and
colleagues6 reported an operative mortality of 10% for
patients operated on over the second half of their experi-
ence, and Roviaro and associates7 quoted a 4% operative
mortality in their experience since 1983. These results are
considerably better than those from earlier reported series
and likely account for the improvement in surgical and
anesthetic techniques. Careful patient selection and detailed
evaluation are also important components to good surgical
results. All our patients have been thoroughly assessed to
Figure 2. The actuarial survival for patients with bronchogenic
carcinoma undergoing carinal resection was significantly better
in patients with pN0/N1 disease than in patients with pN2/N3
disease. The estimated 5-year survival was 53% in patients with
pN0/N1 disease versus 15% in patients with pN2/N3 disease. P 
.0009, log-rank test.determine their physiologic and pulmonary reserve before
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was contemplated.
The surgical approach varied with the type of resection.
A right thoracotomy was always performed for right carinal
pneumonectomy, and a median sternotomy was usually
used for carinal resection with bilateral reconstruction of the
tracheobronchial tree. Left carinal pneumonectomy has
been associated with more controversy as to the type of
surgical approach. Bilateral thoracotomies, left thoracot-
omy, clamshell incision, and median sternotomy have all
been reported with various success.3,6,8 In our experience
we have favored median sternotomy over left thoracotomy
in the past few years. We find that median sternotomy
provides superb exposure to the tracheobronchial bifurca-
tion if a large mobilization of the ascending aorta and
systematic sectioning of the ligamentum arteriosum is per-
formed. In addition, median sternotomy is associated with
less incisional discomfort and results in less ventilatory
restriction than a thoracotomy. The main disadvantages
have been the limited access to release pleuroparietal adhe-
sions and the hemodynamic instability observed during
mobilization of the left hilum because of the cardiac
retraction.
Carinal resection should always be planned without car-
diopulmonary bypass. In our series 3 patients required the
emergency use of cardiopulmonary bypass during the op-
eration. Two patients had intraoperative pulmonary edema
of the left lung, and cardiopulmonary bypass was started to
avoid any significant tension on the suture lines during the
anastomotic procedure.9 The third patient had major bleed-
ing from the right main pulmonary artery that required the
institution of cardiopulmonary bypass to be fixed. None of
the remaining 116 patients required cardiopulmonary by-
pass to undergo carinal resection.
Nine patients died in the hospital or within 30 days of the
operation. Eight of the 9 deaths occurred after right carinal
pneumonectomy. These deaths were due to the development
of pulmonary edema in the initial 24 to 72 hours after the
operation or were the end result of an anastomotic dehis-
cence. The cause of postoperative pulmonary edema is
unknown, but ventilator-induced trauma and excessive fluid
administration during the surgical procedure are often
quoted as the main risk factors.1,10,11 Other risk factors for
the development of postoperative pulmonary edema might
include preoperative alcohol abuse, silent postoperative as-
piration, and/or interference with lymphatic drainage.10,11
Inadequate epithelial ciliary motility of the residual lung can
occur after resection of the carina, but this can usually be
controlled with frequent bronchoscopy in the first few days
postoperatively and did not increase the risk of postopera-
tive death in our experience.
The development of anastomotic complications is likely
due to technical factors at the time of airway resection and
86 The Journal of Thoracic and Cardiovascular Surgery ● Januareconstruction. Careful dissection and precise placement of
anastomotic sutures should limit tissue trauma and avoid
devascularization of the anastomotic site. In addition, air-
way resection should be limited to a maximum of 4 cm at
the carinal level, particularly if a right carinal pneumonec-
tomy is performed and the left mainstem bronchus is to be
reanastomosed end-to-end to the distal trachea.6 Upward
mobilization of the left mainstem bronchus is limited be-
cause of the aortic arch and can easily result in excessive
anastomotic tension. Dissection of the pretracheal plan is
always performed to reduce the tension at the anastomotic
site. However, we do not find that laryngeal or supralaryn-
geal release is useful to reduce the anastomotic tension at
the level of the carina, and we do not routinely use a chin
stitch in these patients.
Long-term survival in patients with bronchogenic carci-
noma reached 53% at 5 years and 31% at 10 years if the
mediastinal nodes were negative. Patients with broncho-
genic carcinoma and positive mediastinal nodes, either N2
or N3, had poor survival, with a 5-year survival of only
15%. Mitchell and coworkers1 reported very similar find-
ings, with a 5-year survival of 51% in patients with N0
disease and 12% in those with N2 or N3 disease. Hence the
presence of metastastic mediastinal nodes in patients requir-
ing carinal resection should be considered a potential con-
traindication. This finding underscores the importance of
performing routine preoperative mediastinoscopy in these
patients. We recommend performing the mediastinoscopy at
the time of the planned carinal resection to avoid the devel-
opment of scaring tissue along the trachea and to take
advantage of the tracheal mobilization to reduce tension at
the anastomotic site.
Further studies should determine the role of induction
therapy in patients presenting with bronchogenic carcinoma
and N2 disease. Induction therapy seems to improve sur-
vival if the mediastinal nodes can be sterilized before the
lung resection.12 However, induction therapy could poten-
tially be associated with increased operative morbidity and
mortality in patients requiring right carinal pneumonec-
tomy. Although induction therapy had no significant effect
on the operative mortality in our series, it was still associ-
ated with an operative mortality that almost doubled. The
operative mortality increased from 6.7% to 13% after in-
duction therapy in patients undergoing right carinal pneu-
monectomy. Other authors have made similar observations
and have reported an operative mortality as high as 24%
after right pneumonectomy after induction therapy.13
Considering the results of recent trials on adjuvant che-
motherapy for patients with completely resected NSCLC,
we now recommend postoperative chemotherapy for most
patients undergoing carinal resection for NSCLC, regard-
less of the nodal status.14,15 However, we consider adjuvant
radiation therapy only in patients with positive resection
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capsular extension.
In conclusion, this study demonstrates that carinal resec-
tion for carcinoma is relatively safe in experienced centers
and can be associated with good long-term survival. Pa-
tients presenting with bronchogenic carcinoma and negative
mediastinal nodes should be considered for carinal resection
without any induction therapy. However, mediastinoscopy
at the time of the planned operation is important because the
presence of positive N2 disease should be considered a
potential contraindication to carinal resection because of the
poor long-term survival.
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Dr Douglas Mathisen (Boston, Mass). This presentation is an-
other example of what we have come to expect from Dr Dartevelle
and his colleagues at Marie Lannelongue in Paris—outstanding
results in a very difficult group of patients.
It was not that many years ago that the risk of operative
mortality equaled the chance for survival, calling into question
whether this was truly a valid operation. To see results of overall
survival of almost 44% and an operative mortality of 7.6% puts
this operation really in the realm of a standard pneumonectomy.
Lest we be deceived, however, to think that these are simple
operations and not challenging, one must remember, as is pointed
out in the article, that these patients require very careful evalua-
tion, strict attention to technical detail in the operating room, a
keen understanding of the limits of resection and reconstruction,
and dedicated postoperative care to achieve these kinds of results.
It is interesting to me how very similar our results are to yours.
Operative mortality is the one area in which we look to your results
as really the gold standard. An operative mortality of 7.6% is truly
remarkable. Ours now in the last half of our experience has been
less than 10%, but long-term survival between 40% and 45%, the
type of complications that you saw, the type of problems that led
to mortality (very similar), and the emphasis on the very poor
outlook conferred when you have positive mediastinal nodes were
very similar to our findings as well.
I have 4 questions. The first is a technical question. In your
article you do not mention whether the anastomosis is covered
with any type of local flap. I wonder whether you would just
comment about some of the technical aspects of carinal resection
through a median sternotomy. You have used that more liberally
than we have, and I think it would be important for the audience
to hear some of the technical points that you think are important
when using that approach.
Dr de Perrot. With regard to the anastomosis, we cover it with
either part of the pleura that is left or the pericardium or even the
azygos vein after its division.
With regard to the carinal resection with a left pneumonectomy,
this is certainly a very challenging group of patients, and over the
past few years, most of the patients were operated on through a
median sternotomy, and the exposure of the tracheobronchial
bifurcation was fairly good. After freeing the ascending aorta and
cutting the arterial ligament, you can expose the tracheobronchial
tree relatively well. The difficulty comes when you have to dissect
the pulmonary veins and when you have to retract the heart, and if
you have to dissect some adhesions within the left pleural chest,
that is where the difficulty comes from. But because of the good
exposure of the tracheobronchial tree, that was the preferred ap-
proach over the past few years. But it is certainly still a very
challenging group of patients.
Dr Mathisen. In the article you mentioned 4 deaths from acute
respiratory distress syndrome. We have seen this as well. Have you
changed your intraoperative management or postoperative care to
address that issue? We have become more and more convinced
that the predominant factor is barotrauma during the operation. Do
you have any thoughts about whether you have changed your
management intraoperatively or postoperatively?
Dr de Perrot. We have not directly changed our management.
These 4 deaths were over a relatively long period as well. But
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edema. Often it resolves after a few days. Some patients require
noninvasive ventilation. If it is not too severe, it just resolves, but
there is no significant factor where we have been able to determine
who is at risk of having pulmonary edema postoperatively, and
certainly we try to avoid damage to the left lung during the
operation with nontraumatic ventilation, and we also try to keep
these patients as dry as possible, as you would do for a pneumo-
nectomy.
The other things we have seen that I did not show is this: if you
look at the right pneumonectomy, in that group of patients, those
who did not have induction therapy had an operative mortality of
about 7%, whereas those who had induction therapy with or
without radiation but with chemotherapy had an operative mortal-
ity of 13%. Therefore that certainly is increasing the risk of
postoperative complications, although it does not show up with
significant results in the data.
Dr Mathisen. The second issue about operative mortality re-
lates to anastomotic problems. I think there were 12 anastomotic
problems that led to 4 deaths. Have you analyzed further in detail
what was responsible for the anastomotic problems? Was it purely
a function of extent of resection, or could it have been other
factors, such as preoperative therapy, mediastinoscopy, or type of
resection?
Dr de Perrot. There was no factor that came out. Certainly the
length of the resection was a risk factor. You very well have shown
in your data that you can resect up to 4 cm, and already between
2 and 4 cm you are increasing the risk. Most of the patients had a
resection of about 2 to 3 cm, and very few had more than 3 cm.
That is the only factor that could come into play, but there were no
factors in these 4 patients that I could really determine from this
analysis.
Dr Mathisen. Were there any patients in this group, of the ones
who had anastomotic problems, who died beyond 30 days as a
result of their anastomotic problem?
Dr de Perrot. There were some, yes. Most of these patients
have been in the hospital for a prolonged period of time. Even
those who survived were in the hospital for a prolonged period of
time, and even though they did not die from the anastomotic
complication, it certainly increases their likelihood of having com-
plications later on down the road, even several months after the
operation. Therefore for these 4 deaths, I do not know quite exactly
when the deaths were, but certainly some of them were beyond 30
days, yes.
Dr Mathisen. Finally, I was particularly struck by the number
of patients who had superior vena cava (SVC) involvement and
equally struck by the good results, survival of, I think, 25 patients,
nearly a 40% survival in this group of patients. I wonder whether
you could comment on the role of adjuvant therapy in that group
and then just a final comment about the adjuvant therapy in this
group at large. I think there was a total of 38 patients who received
some type of adjuvant therapy after carinal resection.
Dr de Perrot. Twenty-five patients had resection of the SVC,
and 13 of them had frank invasion of the SVC and required an
interposition graft. The number has increased progressively over
the years, and most of these patients were operated on over the past
10 years; therefore it is with increasing experience that the
number of patients has increased. Related to the outcome, there are
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group of patients. Overall, the outcome was relatively similar to
that of the patients who had only carinal resection. But this group
at large will benefit from adjuvant therapy, and only 38% of this
cohort of patients had adjuvant therapy because the data were not
supporting adjuvant therapy at that time, except for N2 disease.
Now we have better data proving that adjuvant therapy works for
early-stage lung cancer. Certainly all of these patients should have
at least chemotherapy postoperatively.
Dr Mathisen. Once again, congratulations on a very outstand-
ing report. Thank you.
Dr Alec Patterson (St Louis, Mo). Marc, I would just like to
make a comment and ask you a question. You mentioned the
difficulty of exposing the left hilum through an anterior approach.
In the last year or so, we have been using an anterior approach for
a variety of things, much more commonly than before, and also in
our transplantation experience, which more or less demands an
anterior approach. We found that the cardiac Octopus suction
stabilizer can be very helpful. With this device applied to the apex
of the heart, you can lift the heart vertically out of the mediasti-
num, put it wherever you want without compromising hemody-
namics, and get a beautiful exposure of the left hilum.
You must have an incidence of postpneumonectomy pulmo-
nary edema, particularly in the right carinal pneumonectomy ex-
perience. Do you have a specific protocol for the management of
those patients?
Dr de Perrot. Postoperatively?
Dr Patterson. Yes, for patients who experience postresection
or postpneumonectomy pulmonary edema.
Dr de Perrot. Well, the protocol is really the same as for any
patient with pulmonary edema. The treatment would be to try to
keep them as dry as possible, as long as their kidney function
tolerates. We have a tendency to use bronchoscopy for these
patients very frequently as well. Several of these patients have
sputum retention and cannot cough up very well. Part of it is the
pain, and the other problem is that the clearance of the secretions
is not as good because of the anastomosis. Therefore a large group
of these patients will have a bronchoscopy almost every day really
to help them clear up the secretions. Therefore that would be
another part of the protocol. Otherwise, noninvasive ventilation is
useful, and we try to do everything we can to avoid having to
reintubate them unless it is really necessary. The last thing is that
in some of these patients, if they are not collaborating well enough,
tracheostomy can be a useful tool to help them come through the
postoperative period, and then you can just remove the tracheos-
tomy before they leave the hospital. It is really a useful tool to use
early on rather than later on in these patients, I think.
F. Griffith Pearson (Mansfield, Ontario, Canada). Dr de Per-
rot, I thoroughly enjoyed that clear presentation of quite a great
article, and I will take the opportunity to congratulate Dr Darte-
velle on again bringing an area of controversial and difficult
surgical intervention into perspective and encouraging the rest of
us to be more optimistic and also to pay attention to the details that
are really quite original in many of his prior presentations and this
one.
I was at a meeting in Treviso, and it was 5 or 6 years ago,
maybe more, when Dr Dartevelle presented, I think, 55 cases of
carinal resection, and there was one technical feature in the indi-
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clarify. If I remember correctly, something like 30% or 40% of the
patients had a lesion on the right side, or maybe it was on the left,
but on the right side that was within a centimeter of the carina but
not necessarily involving the carina. I can only say that in the past
I have assumed I was not going to do a carinal resection if I could
divide the airway obliquely and end up with a resection margin
that was histologically free. Therefore I have always wondered
whether some of the patients in that series might have been
manageable by our older standards, by a right pneumonectomy,
and whether that would influence survival. Whether it would
influence survival, nobody can know. But I would like to hear a
response to that. Whether you have had that question asked and
can answer it, I am not sure, but I would appreciate clarification on
that issue.
It was a great paper.
Dr de Perrot. Thank you, Dr Pearson.
That is certainly something I was looking at when I was
reviewing the chart. It is something that I was paying attention to.
It is difficult to retrieve the information from the chart in an
operation like that, but that is an area that I was looking at because
one of the concerns when you have a very short stump on the right
side is that you put too much tension on your closure.
That is one of the risk factors for bronchopleural fistula. ButThe Journal of Thoracwere very close to the trachea. The majority of these patients had
positive microscopic bronchial margins that were within 1 cm of
the carina. Therefore it is not necessarily patients who had invasion
of the carina by the tumor that could be seen at the time of the
bronchoscopy, but certainly a large group of them had a positive
bronchial margin. It is very judgmental to determine whether you
can safely close a stump or whether you have to do a carinal
resection to do a safe procedure. Therefore I could not really
retrieve from the chart, but certainly all these tumors were within
1 cm of the carina, I would say.
Dr W. Roy Smythe (Temple, Tex). I enjoyed your presenta-
tion. It is a great series.
I just have one question about the fact that most of the dehis-
cences were after right carinal pneumonectomies, and with your
inability to do a hilar release on the left side, do you routinely do
a laryngeal release on those patients now? Has that altered your
practice at all?
Dr de Perrot. For the right pneumonectomy, these patients did
not need any hilar release. Those who needed a release were the
patients who had a carinal resection with a right upper lobectomy.
Of the 3, one had a hilar release, and one had a laryngeal release.
But in general none of these patients needed a release, and cer-
tainly the laryngeal release would not have been very useful for the
carina, and therefore the release would have been a pericardialcertainly, from what I could see in the chart, most of these tumors opening around the pulmonary vein.ic and Cardiovascular Surgery ● Volume 131, Number 1 89
